Medpage Today on MSN5d
Higher Comorbidity Burden in Multiple Sclerosis Tied to Worse Outcomes
"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...
Higher burden of comorbidity linked to worse clinical outcomes in multiple sclerosis
For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes, according ...
WINK NEWS1h
Fort Myers woman swims across the North Channel for Multiple Sclerosis
A woman is making a name for herself as the first Floridian to complete a 21-mile swim across the North Channel, from Ireland ...
MedPage Today on MSN7h
McDonald Criteria Revisions Signal Shift Toward MS as a Biologically Based Disease
The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...
AB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis post ECTRIMS 2024
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS POST ECTRIMS 2024 Paris, 23 September 2024, 5.45pm CET AB Science SA (Euronext - ...
Key biomarkers identified for predicting disability progression in multiple sclerosis
A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...
Sanofi’s Multiple Sclerosis Drug Slows Disease’s Progression
Sanofi’s experimental drug for a form of multiple sclerosis delayed the progression of disability by nearly a third, ...
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
Novartis' new data for Kesimpta showed reduced disability progression in relapsing multiple sclerosis patients. Continuous ...
STAT10d
FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug
Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...
Medscape10d
Does Multiple Sclerosis Protect Against Alzheimer's?
Patients with MS showed half the rate of amyloid pathology compared with people without MS, suggesting a possible protective ...
Stories on US FDA approving injectable Roche multiple sclerosis therapy are withdrawn
The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients with multiple ...
Exclusive: Teva faces EU fine for disparaging rival multiple sclerosis medicine, sources say
Teva , the world's largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a ...